The Swedish Asthma and Allergy Research Foundation, Stockholm Report issue

Foundation

Organization Overview

First Clinical Trial
2003
NCT00892684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

The Swedish Asthma and Allergy Research Foundation, Stockholm, Sweden.

Active Ingredients

Drugs in Other Trials (2)

icosapent ethyl (vascepa) (1 trial)

soybean oil (Intralipid) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2